B46.3

Clinical Causes: Infection by fungi of the Mucorales order, such as Rhizopus, Mucor, or Lichtheimia species. Entry of fungi through broken or injured skin, especially in areas with open wounds, burns, or surgical sites. Compromised immune system, which reduces the body's ability to fight off fungal infections, including conditions like uncontrolled diabetes, leukemia, or immunosuppressive therapy. Poorly controlled diabetes, particularly diabetic ketoacidosis, increases susceptibility. Prolonged use of corticosteroid medications. Trauma or injury exposing deep skin tissues to infected soil, decaying organic matter, or contaminated materials. Hospital-acquired infections in immunocompromised patients, especially after invasive procedures or surgeries.

Key Symptoms: Pain, redness, or swelling at the site of infection. Development of a firm or hardened skin lesion that may appear as a rash or ulcer. Rapid progression of skin necrosis, leading to tissue death with blackened areas of skin (sometimes called 'black eschar'). Fever and general malaise in more severe cases. Potential spread to deeper tissues, causing underlying muscle or bone involvement. Discoloration, tenderness, or warmth around the affected area. In some cases, the formation of pustules or abscesses.

Diagnosis Path: Diagnosing cutaneous mucormycosis involves a combination of clinical evaluation and laboratory tests. These include: - Physical examination of the skin lesion and surrounding tissues. - Skin biopsy to examine tissue samples under a microscope for characteristic fungal elements. - Fungal culture to identify the specific Mucorales species. - Imaging studies such as MRI or CT scans to assess the extent of tissue and deep tissue involvement. - Blood tests may be performed to evaluate overall health and immune status. Early diagnosis is crucial for effective treatment and improved outcomes.

Treatment Protocols: Treatment strategies focus on controlling the infection and preventing tissue loss. Approaches include: - Prompt initiation of antifungal therapy, typically using high-dose amphotericin B or newer antifungal agents like posaconazole. - Surgical debridement to remove infected and necrotic tissue, helping to reduce fungal burden and facilitate healing. - Managing underlying conditions, such as controlling blood sugar levels in diabetics. - Supporting the immune system and overall health through appropriate medical interventions. - In some cases, reconstructive surgery may be necessary to repair tissue damage after infection control. - Close monitoring and follow-up to detect potential recurrence or complications.